Entity Addresses, Address Type [Axis]
Business Contact [Member]
Class of Stock [Axis]
American depositary shares (each American depositary share representing one ordinary share)
Ordinary shares, no par value
Related and Nonrelated Parties [Axis]
Nonrelated Party [Member]
Related Party [Member]
Equity Components [Axis]
Common Stock [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Shelf Registration Statement [Member]
American Depository Shares [Member]
Sales Agreement [Member]
Current Sales Agreement [Member]
Statistical Measurement [Axis]
Maximum [Member]
Financial Instrument [Axis]
Available-for-Sale Securities [Member]
Plan Name [Axis]
Equity Incentive Plan 2021 - 2025 [Member]
Award Type [Axis]
Share-Based Payment Arrangement, Option [Member]
Underswriters Common Share Warrants [Member]
Antidilutive Securities [Axis]
Sale of Stock [Axis]
IPO [Member]
Cash and Cash Equivalents [Axis]
US$ Trade Payables [Member]
US$ Time Deposits [Member]
Minimum [Member]
Underswriters Warrants [Member]
ATM Offering Costs [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Tax Period [Axis]
No Expiration Date [Member]
No Expiration Date DL 98/2011 [Member]
Related Party Transaction [Axis]
Research And Development Expense Related Party [Member]
Investment Type [Axis]
Allowance For Corporate Equity [Member]
Accruing Financial Interest Income On Time Deposit [Member]
Title and Position [Axis]
Director and Officers [Member]
Statement of Financial Position Location, Balance [Axis]
Other Noncurrent Assets [Member]
Director And Officers And Employee [Member]
Director [Member]
Officers and Employee [Member]
Statement of Income Location, Balance [Axis]
Research and Development Expense [Member]
General and Administrative Expense [Member]
Accumulated Net Unrealized Gain Loss [Member]
Accumulated Translation Adjustments [Member]
Third Parties [Member]
Product and Service [Axis]
Consultants and Other Third Parties [Member]
Related Parties [Member]
Materials and Supplies [Member]
Compensation [Member]
Travel and Entertainment [Member]
Other [Member]
Consultancy Agreements [Member]
Pierluigi Paracchi [Member]
Naldini [Member]
Dr.Gentner [[Member]
Consultancy [Member]
XDG Biomed LLC [Member]
Mr.Russo [Member]
Richard Slansky [Member]
Scenario [Axis]
First Indication [Member]
Second Indication [Member]
Third Indication [Member]
Amended and Restated OSR License Agreement [Member]
Sublicense Agreement [Member]
Amendment to OSR Amendedand Restated License Agreement [Member]
First Solid Cancer Indication Option Fee [Member]
Second Solid Cancer Indication Option Fee [Member]
OSR Sponsor Research Agreement [Member]
Accounting Legal and Other Professional [Member]
Communication and IT Related [Member]
Facility and Insurance Related [Member]
San Raffaele Hospital OSR [Member]
Carlo Russo [Member]
OSR [Member]
OSR Operating Leases And Office Rent [Member]
OSR - SRA & ARLA [Member]
AGC Manufacturing [Member]
Insurance Policy [Member]
Original OSR License Agreement [Member]
San Raffaele Hospital [Member]
Legal Entity [Axis]
AGC Biologics Agreement [Member]
AGC Agreement [Member]
LVV Batch [Member]
Process Transfer Agreement [Member]
Manufacturing Service Agreement [Member]
Master Service Agreement [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Subscription Agreement [Member]
Mandatory Convertible Bond [Member]
Convertible Bond [Member]
Forecast [Member]
Conversion Shares [Member]
Measurement Input Type [Axis]
Ordinary Conversion Price [Member]
Prior Sales Agreement [Member]
Entity Addresses [Table]
Entity Addresses [Line Items]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Contact Personnel Name
Contact Personnel Email Address
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Auditor Firm ID
Auditor Opinion [Text Block]
Auditor Name
Auditor Location
Income Statement [Abstract]
Operating expenses
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense)
Others income (expense)
Finance income
Net exchange rate gain (loss)
Total other income (expense), net
Loss before income taxes
Income tax benefit (expense)
Net loss
Earnings Per Share, Diluted
Weighted Average Number of Shares Outstanding, Diluted
Other comprehensive income (loss)
Total change of marketable debt securities
Change in foreign currency translation
Total other comprehensive income (loss)
Comprehensive loss
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
Assets
Current assets
Cash and cash equivalents
Marketable Securities
Prepaid expenses and other current assets
Total current assets
Non-current assets
Fixed assets, net
Other non-current assets
Total non-current assets
Total assets
Liabilities and shareholders’ equity
Current liabilities
Accounts payable
Accrued expenses
Other current liabilities
Total current liabilities
Non-current liabilities
Other non current liabilities
Retirement benefit obligation
Total long-term liabilities
Commitments and contingencies
Shareholders’ equity
Ordinary shares, no par value, 59,700,000 shares authorized and 18,289,866 and 18,216,958 shares issued and outstanding respectively
Accumulated deficit
Accumulated other comprehensive income
Total shareholders’ equity
Total liabilities and shareholders’ equity
Statement of Financial Position [Abstract]
Common Stock, Par or Stated Value Per Share
Common Stock, Shares Authorized
Common Stock, Shares, Outstanding
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Share-based compensation
Cumulative Translation Adjustment
Net loss
Capital increase ATM program
Capital increase ATM program, shares
Other comprehensive income (loss)
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities
Adjustments to reconcile net loss to net cash used in operating activities:
Foreign exchange adjustment
Depreciation and amortization expense
Retirement benefit obligation
Share-based compensation
Changes in operating assets and liabilities
Prepaid expenses and other current assets
Other non-current assets
Accounts payable
Accounts payable - related party
Accrued expenses
Accrued expenses - related party
Other current liabilities
Other non-current liabilities
Net cash used in operating activities
Cash flows from investing activities
Purchases of marketable securities
Proceeds from maturities of marketable securities
Purchases of fixed assets
Net cash (used in)/produced by investing activities
Cash flows from financing activities
Proceeds from ATM
Net cash provided by financing activities
Effect of exchange rate changes
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Trading Arrangements, by Individual [Table]
Trading Arrangement [Axis]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management Processes Integrated [Flag]
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity Risk Management Third Party Engaged [Flag]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Material Cybersecurity Incident [Abstract]
Material Cybersecurity Incident Nature [Text Block]
Material Cybersecurity Incident Scope [Text Block]
Material Cybersecurity Incident Timing [Text Block]
Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]
Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of business and history
Accounting Policies [Abstract]
Summary of significant accounting policies
Research and Development [Abstract]
Research and development
General And Administrative
General and administrative
Income Tax Disclosure [Abstract]
Income taxes
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expenses and other current assets
Property, Plant and Equipment [Abstract]
Fixed assets, net
Non-current Assets Right Of Use
Non-current assets right of use (ROU)
Other non-current assets
Retirement Benefits [Abstract]
Retirement benefit obligation
Equity [Abstract]
Shareholders’ equity
Share-Based Payment Arrangement [Abstract]
Share-based compensation
Accumulated other comprehensive income
Related Party Transactions [Abstract]
Related parties
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies
Subsequent Events [Abstract]
Subsequent events
Basis of presentation
Principles of consolidation
Use of estimates
Cash and cash equivalents
Marketable securities
Net loss and comprehensive income (loss)
Net loss per share
Foreign currency translation
Emerging growth company status
Fair value measurements
Segment information
Tax credit on investments in research and development
Share-based compensation
Representative warrants
Non-current assets right of use (ROU)
Fixed Assets
Impairment of long-lived assets
Deferred offering costs
Recently issued accounting pronouncements
Schedule of cash and cash equivalents
Schedule of Marketable securities
Schedule of fair values due to short-term nature of assets and liabilities
Schedule of effective income tax rate reconciliation
Schedule of deferred tax assets
Schedule of tax loss carryforwards expire
Schedule of prepaid expenses and other current assets
Schedule of fixed assets,net
Schedule of other non-current assets
Schedule of Outstanding Stock Options
Schedule of share based compensation expenses
Schedule of Accumulated Other Comprehensive Income
Schedule of third party and general and administrative expenses
Schedule of accounts payable to related parties
Schedule of accrued expenses to related parties
Schedule of company obligations by contractual maturity
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net Income (Loss) Attributable to Parent
Retained Earnings (Accumulated Deficit)
Cash, Cash Equivalents, and Short-Term Investments
Proceeds from Issuance or Sale of Equity
Shares, Issued
Shares, Outstanding
Stock Issued During Period, Value, New Issues
[custom:SaleOfStockAggregateOfferingPrice]
[custom:SaleOfStockValueOfShareAvailableToBeSold]
[custom:SaleOfStockRemainingValueOfShare]
[custom:SaleOfStockAdditionalValueOfShare]
[custom:SaleOfStockCommissionPercentage]
Cash and Cash Equivalents, at Carrying Value
Marketable Securities
Foreign Currency Transaction Loss, before Tax
Cash in bank
Cash in short-term marketable securities
Cash in hand & prepaid cards
Total cash and cash equivalents
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss
Debt Securities, Available-for-Sale, Excluding Accrued Interest
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain (Loss), before Tax
Debt Securities, Available-for-Sale, Allowance for Credit Loss
Platform Operator, Crypto Asset [Table]
Platform Operator, Crypto Asset [Line Items]
Cash and cash equivalents
Marketable Securities
Total financial assets
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Marketable Security, Unrealized Gain (Loss)
Other Comprehensive Income (Loss), Net of Tax
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Stockholders' Equity, Period Increase (Decrease)
Common Stock, Capital Shares Reserved for Future Issuance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)
Gain (Loss), Foreign Currency Transaction, after Tax
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax
Realized Gain (Loss), Foreign Currency Transaction, before Tax
Foreign currency transaction gain realized
Foreign currency transaction loss unrealized
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Number of Shares, Period Increase (Decrease)
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Stock Issued During Period, Shares, New Issues
Class of Warrant or Right, Exercise Price of Warrants or Rights
Deferred Offering Costs
Deferred Income
Income taxes at Italy statutory rate
Permanent differences
Other
Federal Income tax for Genenta INC
Change in valuation allowance
Total provision expense for income taxes
Net operating loss carryforwards
Other temporary differences
Allowance for corporate equity
Total deferred tax assets
Valuation allowance
Net deferred tax assets
Operating Loss Carryforwards [Table]
Operating Loss Carryforwards [Line Items]
Total
[custom:PercentageOfTaxableIncome]
Value Added Tax (VAT)
Research and development tax credit
Advances payments to suppliers
Other current assets
Other prepaids
Total
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Percentage of value added tax
Taxes Payable, Current
Research and Development Expense
Other Assets, Current
Other Prepaid Expense, Current
Software (ERP Implementation)
Computer
Furniture and fixtures
Total fixed assets
Less: accumulated depreciation and amotization
Fixed assets, net
Non-current Assets Right Of Use Rou
Operating Lease, Expense
Operating Lease Expense Monthly Payment
Lessee, Operating Lease, Description
Lessee, Operating Lease, Discount Rate
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
[custom:NetPresentValueOfRightOfUseAssetAndLiability-0]
[custom:OperatingLeaseLiabilitiesCurrent-0]
[custom:OperatingLeaseLiabilitiesNonCurrent-0]
Value Added Tax (VAT)
Research and development tax credit
Other non-current assets
Total other non-current assets
[custom:ProceedsFromValueAddedTaxRefundsReceivedLongTerm]
Security Deposit
Defined contribution plan maximum annual contributions per employee description
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent
Liability, Defined Benefit Plan, Noncurrent
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value
Stock Issued
Weighted Average Number of Shares Outstanding, Basic
Number of options outstanding, Beginning
Weighted average exercise price outstanding, Beginning
Weighted average remaining contractual term outstanding, Beginning
Aggregate intrinsic value outstanding, Beginning
Number of options, Granted
Weighted average exercise price, Granted
[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted]
Aggregate intrinsic value , Granted
Number of options, Vested and exercised
Weighted average exercise price, Vested and exercised
Aggregate intrinsic value, Vested and exercised
Number of options, Cancelled or forfeited
Weighted average exercise price, Cancelled or forfeited
Aggregate intrinsic value, Cancelled or forfeited
Number of options outstanding, Ending
Weighted average exercise price outstanding, Ending
Aggregate intrinsic value outstanding,Ending
Number of options,Exercisable
Weighted average exercise price, Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Aggregate intrinsic value, Exercisable
Number of options outstanding, Expected to vest
Weighted average exercise price outstanding, Expected to vest
Weighted average remaining contractual term (years) Outstanding expected to vest
Aggregate intrinsic value outstanding, Expected to vest
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total
Unrecognized expense
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Purchased for Award
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Beginning Balance
Adjustment for net (gain) loss on marketable securities
Change in fair value of marketable securities
Cumulative translation adjustment
Total
Realized Investment Gains (Losses)
Total
Total
Total
Total
Deferred Tax Assets, Tax Credit Carryforwards, Research
[custom:IncreaseDecreaseInResearchAndDevelopmentExpense]
[custom:ResearchAndDevelopmentTaxCreditsPercentage-0]
General and Administrative Expense
[custom:DecreaseInGeneralAndAdministrativeExpenses]
[custom:DecreaseInAccountingLegalAndOtherProfessional]
[custom:DecreaseInAuditExpenses]
[custom:IncreaseInLegalFees]
[custom:DecreaseInOtherMinorCosts]
[custom:IncreaseInCommunicationAndItRelatedCosts]
[custom:DecreaseInConsultantsAndOtherThirdPartyCosts]
[custom:ConsultantExpense]
[custom:DecreaseInOtherGeneralAndAdministrativeCosts]
[custom:DecreaseInLimitedLiabilityInsuranceCost]
[custom:IncreaseInPatentMaintenanceCosts]
[custom:OtherCumulativeChange]
Salary and Wage, Excluding Cost of Good and Service Sold
[custom:PercentageOfAnnualBonus]
Employee Benefits and Share-Based Compensation
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
Accrued Bonuses, Current
[custom:BonusOutstandingPaid]
Accrued Bonuses
Annual fee
Recurring fees
Employee-related Liabilities
Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold
Share-Based Payment Arrangement, Expense
Deferred Compensation Arrangement with Individual, Compensation Expense
Other Comprehensive Income (Loss), Tax
Future option fees
Upfront fee
Taxes and Licenses
Other Commitments, Description
Operating Costs and Expenses
[custom:OptionFee]
[custom:AgreementFee]
[custom:TotalProjectCashConsideration]
Payments to Acquire in Process Research and Development
Total
Less than a year
1 to 3 years
4 to 5 years
More than 5 years
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Investment Owned, Balance, Principal Amount
Costs and Expenses, Related Party
Manufacturing Costs
[custom:PercentageOfRoyalties]
Potential milestone
Royalty fee percentage
[custom:TechnologyTransferFee]
Advances on Inventory Purchases
Other Inventory, Supplies, Gross
Inventory, Raw Materials, Gross
[custom:CancellationFeesPercentage-0]
Cost, Direct Material
Oil and Gas, Production Cost, Period Cost
Payments for Rent
Lease, Cost
Subsequent Event [Table]
Subsequent Event [Line Items]
Cost of Goods and Services Sold
Debt Instrument, Face Amount
[custom:NumberOfBonds-0]
[custom:DebtInstrumentIssuePrice-0]
[custom:PaymentForBonds]
Banking Regulation, Total Capital, Actual
Debt Instrument, Interest Rate, Stated Percentage
Investment, Interest Rate, Paid in Cash
Debt Instrument, Description
Debt Conversion, Description
Investments
[custom:ProvisionOfBondIndenture]
Ordinary shares, no par value
American depositary shares (each American depositary share representing one ordinary share)
Finance income expenses.
Change of marketable debt securities.
Research and development tax credit.
Percentage of value added tax.
Increase decrease in accounts payable related party.
Increase decrease in accrued liabilities related party.
Research And Development Expense Related Party [Member]
Allowance For Corporate Equity [Member]
Accruing Financial Interest Income On Time Deposit [Member]
Disclosure Of Noncurrent Assets Right of Use [Text Block]
Operating Lease Expense Monthly Payment.
Net present value of right of use asset and liability.
Research and development tax credit non current.
Other Noncurrent Assets.
Defined contribution plan maximum annual contributions per employee description.
Sales Agreement [Member]
Current Sales Agreement [Member]
Cash in short-term marketable securities.
ATM Offering Costs [Member]
Noncurrent Assets Right of Use ROU [Policy Text Block]
Representative Warrants [Policy Text Block]
Underswriters Warrants [Member]
Tax Credit on Investments in Research and Development [Policy Text Block]
Emerging Growth Company Status [Policy Text Block]
Foreign currency transaction gain realized.
US$ Trade Payables [Member]
Foreign currency transaction loss unrealized.
US$ Time Deposits [Member]
Net Loss and Comprehensive Loss [Policy Text Block]
General And Administrative Disclosure [Text Block]
Income tax reconciliation income tax expense benefit at federal income tax rate.
Deferred tax assets allowance for corporate equity.
Percentage of taxable income.
Schedule Of Tax Loss Carryforwards Expire [Table Text Block]
Underswriters Common Share Warrants [Member]
Equity Incentive Plan 2021 - 2025 [Member]
Sale of stock remaining value of share.
Proceeds from value added tax refunds received long term.
American Depository Shares [Member]
Director And Officers And Employee [Member]
Officers and Employee [Member]
Sharebased compensation arrangement by sharebased payment award options outstanding weighted average remaining contractual term granted.
Share based compensation arrangement by share based payment award options cancelled or forfeited aggregate intrinsic value.
Share based compensation arrangement by share based payment award options granted aggregate intrinsic value.
Consultants and Other Third Parties [Member]
Materials and Supplies [Member]
Compensation [Member]
Travel and Entertainment [Member]
Other [Member]
Third Parties [Member]
Related Parties [Member]
Accumulated Net Unrealized Gain Loss [Member]
Accumulated Translation Adjustments [Member]
Director and Officers [Member]
Research and development tax credits percentage.
Accounting Legal and Other Professional [Member]
Communication and IT Related [Member]
Facility and Insurance Related [Member]
Schedule of Accounts Payable to Related Parties [Table Text Block]
Schedule of Accrued Expense to Related Parties [Table Text Block]
Pierluigi Paracchi [Member]
Percentage of annual bonus
Bonus outstanding paid.
Annual fee.
Naldini [Member]
Dr.Gentner [[Member]
Consultancy [Member]
Recurring fees.
XDG Biomed LLC [Member]
Mr.Russo [Member]
Richard Slansky [Member].
Future option fees
First Indication [Member]
Second Indication [Member]
Third Indication [Member]
Upfront fee.
Amended and Restated OSR License Agreement [Member]
Sublicense Agreement [Member]
Amendment to OSR Amendedand Restated License Agreement [Member]
First Solid Cancer Indication Option Fee [Member]
Option fee.
Second Solid Cancer Indication Option Fee [Member]
Agreement fee.
Total project cash consideration.
OSR Sponsor Research Agreement [Member]
OSR [Member]
OSR - SRA & ARLA [Member]
AGC Manufacturing [Member]
Insurance Policy [Member]
Payments by period, less than a year
OSR Operating Leases And Office Rent [Member]
Contractual obligation due in one to third year
Original OSR License Agreement [Member]
San Raffaele Hospital [Member]
Percentage of Royalties.
Royalty fee percentage.
Potential milestone.
AGC Biologics Agreement [Member]
Technology transfer fee.
AGC Agreement [Member]
LVV Batch [Member]
Process Transfer Agreement [Member]
Cancellation fees percentage.
Master Service Agreement [Member]
Manufacturing Service Agreement [Member]
Subscription Agreement [Member]
Mandatory Convertible Bond [Member]
Conversion Shares [Member]
Ordinary Conversion Price [Member]
Prior Sales Agreement [Member]
Decrease in general and administrative expenses.
Decrease in accounting legal and other professional.
Decrease in audit expenses.
Increase in legal fees.
Decrease in other minor costs.
Increase in communication and it related costs.
Decrease in consultants and other third party costs.
Consultant expense.
Consultancy Agreements [Member]
Decrease in other general and administrative costs.
Decrease in limited liability insurance cost.
Increase in patent maintenance costs.
Other cumulative change.
No Expiration Date [Member]
No Expiration Date DL 98/2011 [Member]
San Raffaele Hospital OSR [Member]
Carlo Russo [Member]
Operating lease liabilities current.
Operating lease liabilities non current.
Shelf Registration Statement [Member]
Sale of stock aggregate offering price.
Sale of stock value of share available to be sold.
Sale of stock additional value of share.
Sale of stock commission percentage.
Increase decrease in research and development expense.
Number of bonds.
Convertible Bond [Member]
Debt instrument issue price.
Payment for bonds.
Provision of bond indenture.
Cumulative translation adjustment.
Operating Expenses
Operating Income (Loss)
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Assets, Current
Assets, Noncurrent
Assets [Default Label]
Liabilities, Current
Liabilities, Noncurrent
Equity, Attributable to Parent
Liabilities and Equity
Gain (Loss), Foreign Currency Transaction, before Tax
Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash
Share-Based Payment Arrangement, Noncash Expense
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Other Noncurrent Assets
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Accrued Liabilities
Increase (Decrease) in Other Current Liabilities
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Marketable Securities
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities
Net Cash Provided by (Used in) Financing Activities
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Disposal Group, Including Discontinued Operations
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Research, Development, and Computer Software Disclosure [Text Block]
GeneralAndAdministrativeDisclosureTextBlock
Other Current Assets [Text Block]
Property, Plant and Equipment Disclosure [Text Block]
Other Assets Disclosure [Text Block]
Retirement Benefits [Text Block]
Equity [Text Block]
Share-Based Payment Arrangement [Text Block]
Comprehensive Income (Loss) Note [Text Block]
Commitments and Contingencies Disclosure [Text Block]
Cash and Cash Equivalents, Policy [Policy Text Block]
Share-Based Payment Arrangement, Forfeiture [Policy Text Block]
NoncurrentAssetsRightofUseROUPolicyTextBlock
Marketable Securities [Default Label]
Cash and Cash Equivalents, Fair Value Disclosure
Securities Borrowed, Fair Value Disclosure
Deferred Tax Assets, Gross
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance
Prepaid Expense, Current
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Value Added Tax Receivable, Noncurrent
ResearchAndDevelopmentTaxCreditNoncurrent
Other Noncurrent Assets
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Accrued Liabilities
Contractual Obligation